These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 18794103)

  • 1. Gene expression profiling reveals similarities between the in vitro and in vivo responses of immune effector cells to IFN-alpha.
    Zimmerer JM; Lesinski GB; Ruppert AS; Radmacher MD; Noble C; Kendra K; Walker MJ; Carson WE
    Clin Cancer Res; 2008 Sep; 14(18):5900-6. PubMed ID: 18794103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiparametric flow cytometric analysis of inter-patient variation in STAT1 phosphorylation following interferon Alfa immunotherapy.
    Lesinski GB; Kondadasula SV; Crespin T; Shen L; Kendra K; Walker M; Carson WE
    J Natl Cancer Inst; 2004 Sep; 96(17):1331-42. PubMed ID: 15339971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IFN-alpha-2b-induced signal transduction and gene regulation in patient peripheral blood mononuclear cells is not enhanced by a dose increase from 5 to 10 megaunits/m2.
    Zimmerer JM; Lehman AM; Ruppert AS; Noble CW; Olencki T; Walker MJ; Kendra K; Carson WE
    Clin Cancer Res; 2008 Mar; 14(5):1438-45. PubMed ID: 18316567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon alfa regulated gene expression in patients initiating interferon treatment for chronic hepatitis C.
    Ji X; Cheung R; Cooper S; Li Q; Greenberg HB; He XS
    Hepatology; 2003 Mar; 37(3):610-21. PubMed ID: 12601359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression profiling of peripheral-blood mononuclear cells from patients with chronic hepatitis C undergoing interferon therapy.
    Tateno M; Honda M; Kawamura T; Honda H; Kaneko S
    J Infect Dis; 2007 Jan; 195(2):255-67. PubMed ID: 17191171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant bacillus Calmette-Guérin (BCG) expressing interferon-alpha 2B enhances human mononuclear cell cytotoxicity against bladder cancer cell lines in vitro.
    Liu W; O'Donnell MA; Chen X; Han R; Luo Y
    Cancer Immunol Immunother; 2009 Oct; 58(10):1647-55. PubMed ID: 19214503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-12 pretreatments enhance IFN-alpha-induced Janus kinase-STAT signaling and potentiate the antitumor effects of IFN-alpha in a murine model of malignant melanoma.
    Lesinski GB; Badgwell B; Zimmerer J; Crespin T; Hu Y; Abood G; Carson WE
    J Immunol; 2004 Jun; 172(12):7368-76. PubMed ID: 15187113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down-regulation of the interferon signaling pathway in T lymphocytes from patients with metastatic melanoma.
    Critchley-Thorne RJ; Yan N; Nacu S; Weber J; Holmes SP; Lee PP
    PLoS Med; 2007 May; 4(5):e176. PubMed ID: 17488182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiparametric flow cytometric analysis of signal transducer and activator of transcription 5 phosphorylation in immune cell subsets in vitro and following interleukin-2 immunotherapy.
    Varker KA; Kondadasula SV; Go MR; Lesinski GB; Ghosh-Berkebile R; Lehman A; Monk JP; Olencki T; Kendra K; Carson WE
    Clin Cancer Res; 2006 Oct; 12(19):5850-8. PubMed ID: 17020993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological changes in peripheral blood mononuclear cells of patients with metastatic renal cell carcinoma after low doses of subcutaneous immunotherapy with IFN-alpha-2b and IL-2.
    Moltó L; Carballido J; Manzano L; Martinez-Martin B; Esquivel F; Chafer J; Olivier C; Alvarez-Mon M
    J Immunother; 1999 May; 22(3):260-7. PubMed ID: 10335486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Raf Kinase Inhibitor Sorafenib Inhibits JAK-STAT Signal Transduction in Human Immune Cells.
    Martin del Campo SE; Levine KM; Mundy-Bosse BL; Grignol VP; Fairchild ET; Campbell AR; Trikha P; Mace TA; Paul BK; Jaime-Ramirez AC; Markowitz J; Kondadasula SV; Guenterberg KD; McClory S; Karpa VI; Pan X; Olencki TE; Monk JP; Mortazavi A; Tridandapani S; Lesinski GB; Byrd JC; Caligiuri MA; Shah MH; Carson WE
    J Immunol; 2015 Sep; 195(5):1995-2005. PubMed ID: 26238487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular signatures of peripheral blood mononuclear cells during chronic interferon-α treatment: relationship with depression and fatigue.
    Felger JC; Cole SW; Pace TW; Hu F; Woolwine BJ; Doho GH; Raison CL; Miller AH
    Psychol Med; 2012 Aug; 42(8):1591-603. PubMed ID: 22152193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-vitro IL-2 or IFN-α-induced NKG2D and CD161 NK cell receptor expression indicates novel aspects of NK cell activation in metastatic melanoma patients.
    Konjević G; Mirjačić Martinović K; Vuletić A; Babović N
    Melanoma Res; 2010 Dec; 20(6):459-67. PubMed ID: 20938360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune response in blood and tumour tissue in patients with metastatic malignant melanoma treated with IL-2, IFN alpha and histamine dihydrochloride.
    Jørkov AS; Donskov F; Steiniche T; Ternesten-Bratel A; Naredi P; Hellstrand K; Hokland M
    Anticancer Res; 2003; 23(1B):537-42. PubMed ID: 12680142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Interferon-alpha1b (IFN-α1b) on Antitumor Immune Response: An Interpretation of the Promising Therapeutic Effect of IFN-alpha1b on Melanoma.
    Liu Y; Ma J; Yang Y; Liu L; Zhu G; Wang X; Wang S; Guo W; Yue Q; Zhao T; Li C; Gao T; Shi Q
    Med Sci Monit; 2020 Mar; 26():e922790. PubMed ID: 32210221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melanoma cells exhibit variable signal transducer and activator of transcription 1 phosphorylation and a reduced response to IFN-alpha compared with immune effector cells.
    Lesinski GB; Trefry J; Brasdovich M; Kondadasula SV; Sackey K; Zimmerer JM; Chaudhury AR; Yu L; Zhang X; Crespin TR; Walker MJ; Carson WE
    Clin Cancer Res; 2007 Sep; 13(17):5010-9. PubMed ID: 17785551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IFN-alpha-induced signal transduction, gene expression, and antitumor activity of immune effector cells are negatively regulated by suppressor of cytokine signaling proteins.
    Zimmerer JM; Lesinski GB; Kondadasula SV; Karpa VI; Lehman A; Raychaudhury A; Becknell B; Carson WE
    J Immunol; 2007 Apr; 178(8):4832-45. PubMed ID: 17404264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Study of Immune Response in PBMC of CHB Patients treated with IFN-α and 3-TC in vitro.
    Zhang H; Guan ZS; Guan SH; Yang K; Pan Y; Wu YY; Wang AH; Sun BB; Hou J; Mu XX; Gao YF; Cheng WS
    Clin Lab; 2016 Dec; 62(12):2313-2318. PubMed ID: 28164560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and immunologic effects of subcutaneously administered interleukin-12 and interferon alfa-2b: phase I trial of patients with metastatic renal cell carcinoma or malignant melanoma.
    Alatrash G; Hutson TE; Molto L; Richmond A; Nemec C; Mekhail T; Elson P; Tannenbaum C; Olencki T; Finke J; Bukowski RM
    J Clin Oncol; 2004 Jul; 22(14):2891-900. PubMed ID: 15254058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of cross-talk between IFN-alpha-induced monocyte-derived dendritic cells and NK cells in priming CD8+ T cell responses against human tumor antigens.
    Tosi D; Valenti R; Cova A; Sovena G; Huber V; Pilla L; Arienti F; Belardelli F; Parmiani G; Rivoltini L
    J Immunol; 2004 May; 172(9):5363-70. PubMed ID: 15100276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.